WeChat Mini Program
Old Version Features

Data from Preclinical Development of the Class-I–Selective Histone Deacetylase Inhibitor OKI-179 for the Treatment of Solid Tumors

Jennifer R. Diamond,Todd M. Pitts,Dana Ungermannova,Christopher G. Nasveschuk,Gan Zhang,Andrew J. Phillips,Stacey M. Bagby,Jessica Pafford,Betelehem W. Yacob,Timothy P. Newton,John J. Tentler,Brian Gittleman,Sarah J. Hartman,John A. DeMattei,James D. Winkler,Michael K. Wendt,William P. Schiemann,S. Gail Eckhardt,Xuedong Liu,Anthony D. Piscopio

MOLECULAR CANCER THERAPEUTICS（2022）

Cited 10|Views23
Key words
HDAC Inhibitors,Histone Deacetylases
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined